Glycoside Hydrolase Inhibitors [inhibitory glykosidových hydrolas]

topical
47
Terms

alfa-amyláza - inhibitory
alfa-glukosidáza - inhibitory
inhibitory alfa-glukosidasy
inhibitory alfa-glukosidáz
inhibitory alfa-glukosidázy
inhibitory glykosidhydrolas
inhibitory glykosidové hydrolázy
inhibitory glykosidových hydroláz
inhibitory hydroláz glykosidů
inhibitory intestinální alfa-amylasy
inhibitory intestinální alfa-amylázy
inhibitory pankreatické alfa-amylasy
inhibitory pankreatické alfa-amylázy
pankreatická alfa-amyláza - inhibitory

 

alpha-Amylase Inhibitors, Pancreatic
alpha-Glucosidase Inhibitor
alpha-Glucosidase Inhibitors
Intestinal alpha-Amylase Inhibitors
Pancreatic alpha-Amylase Inhibitors

Persistent link   https://www.medvik.cz/link/D065089
Definition

Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES.

DUI
D065089 MeSH Browser
CUI
M000594800
Previous indexing
alpha-Glucosidases/Antagonists and Inhibitors (1978-2014)
History note
2015
Public note
2015

Allowable subheadings

AD
administration & dosage
AE
adverse effects 2
AN
analysis
BL
blood
CF
cerebrospinal fluid
CS
chemical synthesis
CH
chemistry 2
CL
classification
EC
economics
HI
history
IM
immunology
IP
isolation & purification 2
ME
metabolism
PK
pharmacokinetics 1
PD
pharmacology 6
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use 5
TO
toxicity
UR
urine

D Chemicals and Drugs
D27 Chemical Actions and Uses 374
D27.505 Pharmacologic Actions 409
D27.505.519 Molecular Mechanisms of Pharmacological Action 89
D27.505.519.389 Enzyme Inhibitors 881
D27.505.519.389.086 5-Lipoxygenase-Activating Protein Inhibitors 3
D27.505.519.389.089 Acetaldehyde Dehydrogenase Inhibitors 2
D27.505.519.389.092 Adenosine Deaminase Inhibitors 6
D27.505.519.389.108 Adenylyl Cyclase Inhibitors 14
D27.505.519.389.124 Aromatic Amino Acid Decarboxylase Inhibitors 8
D27.505.519.389.174 Calcineurin Inhibitors 123
D27.505.519.389.200 Carbonic Anhydrase Inhibitors 60
D27.505.519.389.237 Catechol O-Methyltransferase Inhibitors 31
D27.505.519.389.275 Cholinesterase Inhibitors 967
D27.505.519.389.310 Cyclooxygenase Inhibitors 454
D27.505.519.389.315 Gamma Secretase Inhibitors and Modulators
D27.505.519.389.320 Glycoside Hydrolase Inhibitors 47
D27.505.519.389.335 Cytochrome P-450 Enzyme Inhibitors 93
D27.505.519.389.350 Folic Acid Antagonists 67
D27.505.519.389.360 Histone Deacetylase Inhibitors 110
D27.505.519.389.370 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 844
D27.505.519.389.375 Integrase Inhibitors 4
D27.505.519.389.400 beta-Lactamase Inhibitors 75
D27.505.519.389.480 Lipoxygenase Inhibitors 51
D27.505.519.389.616 Monoamine Oxidase Inhibitors 155
D27.505.519.389.675 Nucleic Acid Synthesis Inhibitors 33
D27.505.519.389.705 Ornithine Decarboxylase Inhibitors 3
D27.505.519.389.735 Phosphodiesterase Inhibitors 405
D27.505.519.389.736 Phosphoinositide-3 Kinase Inhibitors 33
D27.505.519.389.737 Phospholipase A2 Inhibitors 9
D27.505.519.389.739 Poly(ADP-ribose) Polymerase Inhibitors 189
D27.505.519.389.740 Prolyl-Hydroxylase Inhibitors 3
D27.505.519.389.745 Protease Inhibitors 273
D27.505.519.389.755 Protein Kinase Inhibitors 1 377
D27.505.519.389.760 Protein Synthesis Inhibitors 37
D27.505.519.389.848 Proton Pump Inhibitors 493
D27.505.519.389.870 Steroid Synthesis Inhibitors 1
D27.505.519.389.892 Topoisomerase Inhibitors 7
D27.505.519.389.936 Uncoupling Agents 24
D27.505.696 Physiological Effects of Drugs 52
D27.505.696.422 Hypoglycemic Agents 2 744
D27.505.696.422.125 Glucagon-Like Peptide-1 Receptor Agonists 34
D27.505.696.422.249 Glycoside Hydrolase Inhibitors 47
D27.505.696.422.374 Amylin Receptor Agonists
D27.505.696.422.500 Dipeptidyl-Peptidase IV Inhibitors 574
D27.505.696.422.625 Insulin Secretagogues
D27.505.696.422.688 PPAR-gamma Agonists
D27.505.696.422.750 Sodium-Glucose Transporter 2 Inhibitors 794

Add